Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications

Author:

Choi Hyunmi1,Hayat Matthew J.2,Zhang Ruiqi3,Hirsch Lawrence J.4,Bazil Carl W.1,Mendiratta Anil1,Kato Kenneth1,Javed Asif1,Legge Alexander W.1,Buchsbaum Richard5,Resor Stanley5,Heiman Gary A.6

Affiliation:

1. Department of Neurology; Columbia University; New York New York U.S.A

2. School of Public Health; Georgia State University; Atlanta Georgia U.S.A

3. Department of Applied Mathematics and Statistics; State University of New York at Stony Brook; Stony Brook New York U.S.A

4. Department of Neurology; Yale University; New Haven Connecticut U.S.A

5. Department of Biostatistics; Mailman School of Public Health at Columbia University; New York New York U.S.A

6. Department of Genetics; The Human Genetics Institute of New Jersey; Rutgers; The State University of New Jersey; Piscataway New Jersey U.S.A

Funder

Elan

GlaxoSmithKline

Novartis

Ortho-McNeill

Pfizer

Eisai

UCB Pharma

Lundbeck

Sunovion

Upsher-Smith

Neuropace

National Institute of Mental Health

Publisher

Wiley

Subject

Clinical Neurology,Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3